Both companies are also expanding beyond obesity into adjacent conditions, which could reinforce the long-term investment case
Even with two players and a supply shortage, were seeing competition at work to be at the top of the formulary, at the top of providers minds, at the top of patients minds
Millions of people taking semaglutide for weight loss wonder about musculoskeletal side effects
Most people experience side effects About 80 percent of adults taking tirzepatide or semiglutide, the active ingredients in the most commonly prescribed GLP-1s, experienced at least one side effect, according to a 2024 review study published in the journal Obesity Pillars
For instance, its extract significantly inhibits the lipopolysaccharide (LPS)-induced transcription of inflammatory cytokines (TNF-, IL-1 and IL-6) in RAW 264.7 cellsa well-established in vitro model for innate immune screening (Zhao et al., 2021)
& Hazen, S